ABBOTT INDIA LIMITED
- Country
- 🇮🇳India
- Ownership
- Private
- Established
- 1888-01-01
- Employees
- 73K
- Market Cap
- $7.5B
- Website
- http://www.abbott.com
Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD)
- First Posted Date
- 2008-06-19
- Last Posted Date
- 2011-04-19
- Lead Sponsor
- Abbott
- Target Recruit Count
- 107
- Registration Number
- NCT00701805
Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid Arthritis
- First Posted Date
- 2008-06-04
- Last Posted Date
- 2012-09-10
- Lead Sponsor
- Abbott
- Target Recruit Count
- 25
- Registration Number
- NCT00690573
- Locations
- 🇯🇵
Site Reference ID/Investigator# 47248, Aichi, Japan
🇯🇵Site Reference ID/Investigator# 47243, Tokyo, Japan
🇯🇵Site Reference ID/Investigator# 47244, Tokyo, Japan
A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and Ezetimibe
- Conditions
- Interventions
- First Posted Date
- 2008-05-21
- Last Posted Date
- 2010-10-19
- Lead Sponsor
- Abbott
- Target Recruit Count
- 18
- Registration Number
- NCT00681525
- Locations
- 🇺🇸
Site Reference ID/Investigator# 8087, Gainesville, Florida, United States
Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives
- Conditions
- Interventions
- First Posted Date
- 2008-05-19
- Last Posted Date
- 2008-05-19
- Lead Sponsor
- Abbott
- Target Recruit Count
- 171
- Registration Number
- NCT00679653
Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian Population
- First Posted Date
- 2008-05-14
- Last Posted Date
- 2008-05-14
- Lead Sponsor
- Abbott
- Target Recruit Count
- 103
- Registration Number
- NCT00677391
A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis
- First Posted Date
- 2008-04-28
- Last Posted Date
- 2012-01-26
- Lead Sponsor
- Abbott
- Target Recruit Count
- 41
- Registration Number
- NCT00667355
- Locations
- 🇯🇵
Site Reference # / Investigator 46782, Hokkaido, Japan
🇯🇵Site Reference # / Investigator 46791, Aichi, Japan
🇯🇵Site Reference # / Investigator 46798, Fukuoka, Japan
Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis
- Conditions
- Interventions
- First Posted Date
- 2008-04-28
- Last Posted Date
- 2012-01-20
- Lead Sponsor
- Abbott
- Target Recruit Count
- 153
- Registration Number
- NCT00667576
A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC)
- Conditions
- Interventions
- First Posted Date
- 2008-04-25
- Last Posted Date
- 2012-04-27
- Lead Sponsor
- Abbott
- Target Recruit Count
- 7
- Registration Number
- NCT00666692
- Locations
- 🇺🇸
Site Reference ID/Investigator# 70333, Hershey, Pennsylvania, United States
🇺🇸Site Reference ID/Investigator# 70355, Greenville, South Carolina, United States
🇺🇸Site Reference ID/Investigator# 70354, Bethesda, Maryland, United States
Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects
- Conditions
- Interventions
- First Posted Date
- 2008-04-23
- Last Posted Date
- 2012-01-20
- Lead Sponsor
- Abbott
- Target Recruit Count
- 13
- Registration Number
- NCT00664430
- Locations
- 🇧🇷
Site Reference ID/Investigator# 7118, Sao Paulo, Brazil
🇧🇷Site Reference ID/Investigator# 7114, Sao Paulo, Brazil
Study of Lupron Depot In The Treatment of Central Precocious Puberty
- First Posted Date
- 2008-04-17
- Last Posted Date
- 2011-04-12
- Lead Sponsor
- Abbott
- Target Recruit Count
- 55
- Registration Number
- NCT00660010
- Locations
- 🇺🇸
Site Reference ID/Investigator# 14343, Aurora, Colorado, United States
🇺🇸Site Reference ID/Investigator# 46673, Phoenix, Arizona, United States
🇺🇸Site Reference ID/Investigator# 14341, St. Petersburg, Florida, United States